11 FOP Presentations Will Be Made At The Annual Meeting
Each year, the American Society of Bone & Mineral Research (ASBMR) holds a scientific meeting for researchers to present their latest findings in bone research. More than 3,000 scientists from around the world attend this important research meeting.This year, at the 2019 ASBMR Annual Meeting, FOP clinical trials are featured in a Rare Bone Disease Working Group Meeting. There will also be 11 presentations related to FOP! We would like to congratulate the researchers who had their abstract or presentation accepted by the ASBMR, see below. The 2019 ASBMR meeting will be held in Orlando, Florida, USA, September 20 to 23.
Robyn Allen
University of Pennsylvania, United States
Multiple modalities of signaling by FOP mutant BMP receptor in the developing zebrafish
Esmée Botman, PhD
Nanditha Das
Regeneron Pharmaceuticals, United States
Inhibition of Activin A does not ameliorate the formation of trauma-induced heterotopic ossification
Alison Davis
Mai Kuratani
Ton Schoenmaker, BSc
Academic Centre for Dentistry Amsterdam, The Netherlands
Activin-A induces fewer, but larger, osteoclasts from CD14+ monocytes in both healthy controls and fibrodysplasia ossificans progressiva patients
Alexandra Stanley
Amy Ton, MD
Chengzhu Zhao
Kyoto University, Japan
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva models by an mTOR signaling modulator
Maurizio Pacifici, PhD
University of Pennsylvania, United States
Fibrodysplasia ossificans progressiva and multiple hereditary exostoses
Eduardo Forleo Neto, MD, MSc
Regeneron Pharmaceuticals, United States
Fibrodysplasia ossificans progressiva
Tim LaBranche, DVM, PhD
Blueprint Medicines, United States
Fibrodysplasia ossificans progressiva
